BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed REPL catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:bf8bb50d21a47dc23724@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260730
DTEND;VALUE=DATE:20260731
SUMMARY:REPL ADCOM (scheduled): AdCom 2026-07-30: Cellular\, Tissue\, and G
 ene Therapies Advisory Committee - BLA 125827
DESCRIPTION:AdCom 2026-07-30: Cellular\, Tissue\, and Gene Therapies Adviso
 ry Committee - BLA 125827\nConfidence: scheduled\nTicker REPL (confidence 
 0.9)\nSource: https://www.federalregister.gov/documents/2026/07/08/2026-13
 810/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meetin
 g-establishment-of-a-public\nScheduling/reference data from public records
 \; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.federalregister.gov/documents/2026/07/08/2026-13810/cellula
 r-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establish
 ment-of-a-public
CATEGORIES:adcom,scheduled
END:VEVENT
BEGIN:VEVENT
UID:0671d1eca5361d55fba0@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260730
DTEND;VALUE=DATE:20260731
SUMMARY:REPL ADCOM (scheduled): AdCom 2026-07-30: Cellular\, Tissue\, and G
 ene Therapies Advisory Committee - BLA 125827
DESCRIPTION:AdCom 2026-07-30: Cellular\, Tissue\, and Gene Therapies Adviso
 ry Committee - BLA 125827\nConfidence: scheduled\nTicker REPL (confidence 
 0.9)\nSource: https://www.federalregister.gov/documents/2026/07/24/2026-15
 017/cellular-tissue-and-gene-therapies-advisory-committee-notice-of-meetin
 g-establishment-of-a-public\nScheduling/reference data from public records
 \; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.federalregister.gov/documents/2026/07/24/2026-15017/cellula
 r-tissue-and-gene-therapies-advisory-committee-notice-of-meeting-establish
 ment-of-a-public
CATEGORIES:adcom,scheduled
END:VEVENT
BEGIN:VEVENT
UID:22a4be3a5d82ff9ecf67@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260410
DTEND;VALUE=DATE:20260411
SUMMARY:REPL CRL: CRL 2026-04-10: Replimune\, Inc. BL 125827
DESCRIPTION:CRL 2026-04-10: Replimune\, Inc. BL 125827\nConfidence: confirm
 ed\nTicker REPL (confidence 0.9)\nSource: https://download.open.fda.gov/cr
 l/CRL_BLA125827_20260410.pdf\nScheduling/reference data from public record
 s\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://download.open.fda.gov/crl/CRL_BLA125827_20260410.pdf
CATEGORIES:crl,confirmed
END:VEVENT
END:VCALENDAR
